Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis

被引:375
作者
Adya, Raghu [1 ]
Tan, Bee K. [1 ]
Punn, Anu [1 ]
Chen, Jing [1 ]
Randeva, Harpal S. [1 ]
机构
[1] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Endocrinol & Metab Grp, Coventry CV4 7AL, W Midlands, England
关键词
matrix metalloproteinases; VEGF; MAPK; PI3K/Akt; endothelial factors; visfatin;
D O I
10.1093/cvr/cvm111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Visfatin is a novel adipokine whose plasma concentrations are altered in obesity and obesity-related disorders; these states are associated with an increased incidence of cardiovascular disease. We therefore investigated the effect of visfatin on vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP-2, MMP-9) production and the potential signalling cascades. Methods and results In human umbilical vein endothelial cells (HUVECs), visfatin significantly and dose-dependently up-regulated gene expression and protein production of VEGF and MMPS and down-regulated expression of tissue inhibitors of MMPs (TIMP-1 and TIMP-2). The gelatinolytic activity of MMPs (analysed by zymography) correlated with mRNA and western blot findings. Interestingly, visfatin significantly up-regulated VEGF receptor 2 expression. Inhibition of VEGFR2 and VEGF [by soluble FMS-like tyrosine kinase-1 (sFlt1)] down-regulated visfatin-induced MMP induction. Visfatin induced dose-and time-dependent proliferation and capillary-like tube formation. Importantly, visfatin was noted to have anti-apoptotic effects. In HUVECs, visfatin dose-dependently activated PI3K/Akt (phosphatidylinositol 3-kinase/Akt) and ERK1/2 (extracellular signal-regulated kinase) pathways. The functional effects and MMP/VEGF induction were shown to be dependent on the MAPK/PI3K-Akt/VEGF signalling pathways. Inhibition of PI3K/Akt and ERK1/2 pathways led to significant decrease of visfatin-induced MMP and VEGF production and activation, along with significant reduction in endothelial proliferation and capillary tube formation. Conclusion Our data provide the first evidence of visfatin-induced endothelial VEGF and AAMP production and activity. Further, we show for the first time the involvement of the MAPK and PI3K/Akt signalling pathways in mediating these actions, as welt as endothelial cell proliferation. Collectively, our findings provide novel insights into visfatin-induced endothelial angiogenesis.
引用
收藏
页码:356 / 365
页数:10
相关论文
共 45 条
[1]   Akt1/protein kinase Bα is critical for ischemic and VEGF-mediated angiogenesis [J].
Ackah, E ;
Yu, J ;
Zoellner, S ;
Iwakiri, Y ;
Skurk, C ;
Shibata, R ;
Ouchi, N ;
Easton, RM ;
Galasso, G ;
Birnbaum, MJ ;
Walsh, K ;
Sessa, WC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2119-2127
[2]   Keeping in touch with angiogenesis [J].
Aiello, LP .
NATURE MEDICINE, 2000, 6 (04) :379-381
[3]   SMOOTH-MUSCLE CELL-MIGRATION AND MATRIX METALLOPROTEINASE EXPRESSION AFTER ARTERIAL INJURY IN THE RAT [J].
BENDECK, MP ;
ZEMPO, N ;
CLOWES, AW ;
GALARDY, RE ;
REIDY, MA .
CIRCULATION RESEARCH, 1994, 75 (03) :539-545
[4]   SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro [J].
Boguslawski, G ;
McGlynn, PW ;
Harvey, KA ;
Kovala, AT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) :5716-5724
[5]   Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities [J].
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1360-1369
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[8]   Decreased plasma visfatin concentrations in women with gestational diabetes mellitus [J].
Chan, Te-Fu ;
Chen, Yi-Ling ;
Lee, Chien-Hung ;
Chou, Fan-Hao ;
Wu, Lee-Chen ;
Jong, Shiang-Bin ;
Tsai, Eing-Mei .
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (05) :364-367
[9]   Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [J].
Chen, MP ;
Chung, FM ;
Chang, DM ;
Tsai, JCR ;
Huang, HF ;
Shin, SJ ;
Lee, YJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :295-299
[10]   Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure? [J].
Creemers, EEJM ;
Cleutjens, JPM ;
Smits, JFM ;
Daemen, MJAP .
CIRCULATION RESEARCH, 2001, 89 (03) :201-210